Scarica l'app Stockscreener
5.26
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SGHT Giù?
Forum
Previsione
Precedente Chiudi:
$5.26
Aprire:
$5.26
Volume 24 ore:
95,835
Relative Volume:
0.42
Capitalizzazione di mercato:
$286.20M
Reddito:
$79.55M
Utile/perdita netta:
$-37.25M
Rapporto P/E:
-7.4568
EPS:
-0.7054
Flusso di cassa netto:
$-25.40M
1 W Prestazione:
+7.13%
1M Prestazione:
-2.95%
6M Prestazione:
-16.24%
1 anno Prestazione:
+57.96%
Intervallo 1D:
$5.10
$5.31
Intervallo di 1 settimana:
$4.91
$5.58
Portata 52W:
$3.11
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Nome
Sight Sciences Inc
Settore
Industria
Telefono
(415) 889-0550
Indirizzo
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
5.26 | 278.58M | 79.55M | -37.25M | -25.40M | -0.7054 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | Aggiornamento | Lake Street | Hold → Buy |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-11-04 | Downgrade | Lake Street | Buy → Hold |
| 2024-08-21 | Iniziato | Lake Street | Buy |
| 2023-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2022-10-04 | Iniziato | Needham | Hold |
| 2022-07-26 | Iniziato | Stifel | Hold |
| 2022-02-03 | Iniziato | William Blair | Outperform |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Sight Sciences Inc Borsa (SGHT) Ultime notizie
Sight Sciences Inc (SGHT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sight Sciences Market Sentiment - Benzinga España
Sight Sciences Inc (SGHT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sight Sciences Inc (SGHT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
SGHT|Sight Sciences Inc|Price:5.130|Chg%:+0.220 - TradingKey
Sight Sciences Inc (SGHT) Institutional Confidence - TradingKey
SGHT|Sight Sciences Inc|Price:4.910|Chg%:+0.210 - TradingKey
Sight Sciences to report Q2 2026 results on August 5 - scanx.trade
Sight Sciences schedules results webcast for Aug. 5 at 4:30 p.m. ET - Stock Titan
Sight Sciences wins $34M patent ruling against Alcon - MSN
Have Insiders Sold Sight Sciences Shares Recently? - simplywall.st
Sight Sciences (SGHT) Declines 1.68% as Stock Hovers Near Critical SupportRelative Volume - dars.gov.et
Sight Sciences Inc focuses on glaucoma devices as investors watch Nasdaq trading - AD HOC NEWS
SGHT Maintained by Citigroup -- Price Target Raised to $6.00 - GuruFocus
Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Raises Target Price to $6 - Moomoo
SGHT stock keeps a focus on Sight Sciences' business model. - Ad-hoc-news.de
Price to earnings forward of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
Sight Sciences CEO Paul Badawi disposes of $155,467 in stock By Investing.com - Investing.com India
Sight Sciences CTO David Badawi sells $40,858 in stock By Investing.com - Investing.com Australia
Sight Sciences CFO James Rodberg sells $36,994 in common shares By Investing.com - Investing.com Australia
Sight Sciences EVP Brenton Taylor sells $15,333 in company stock By Investing.com - Investing.com India
Form 4 Sight Sciences Inc For: 6 July By Investing.com - Investing.com Nigeria
Sight Sciences CTO David Badawi sells $40,858 in stock - Investing.com
Sight Sciences COO Alison Bauerlein sells $129,626 in stock - Investing.com
Form 144 Sight Sciences For: 6 July By Investing.com - Investing.com Nigeria
Sight Sciences COO Alison Bauerlein sells $129,626 in stock By Investing.com - Investing.com Nigeria
Sight Sciences CLO Jeremy Hayden sells $70,133 in stock By Investing.com - Investing.com South Africa
Sight Sciences (SGHT) CEO’s 28,684-share tax sale and updated holdings - Stock Titan
Sight Sciences CEO Paul Badawi disposes of $155,467 in stock - Investing.com
Sight Sciences (NASDAQ: SGHT) CLO sells 12,733 shares to cover RSU taxes - Stock Titan
Sight Sciences (NASDAQ: SGHT) CFO sells 6,902 shares to cover RSU tax bill - Stock Titan
Sight Sciences (SGHT) CTO sells 7,418 shares to cover RSU tax liability - Stock Titan
Sight Sciences (SGHT) EVP sells shares to cover RSU-related tax obligations - Stock Titan
Sight Sciences (SGHT) COO sells shares to cover RSU tax, retains 664,709 stake - Stock Titan
[144] Sight Sciences, Inc. SEC Filing - Stock Titan
SGHT (NASDAQ: SGHT) affiliate files Form 144 to sell 12,733 shares - Stock Titan
Enterprise value to EBITDA forward of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
Enterprise value to EBIT forward of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
Price to book forward of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
Sight Sciences Inc. (SGHT) Holds Steady Near Support as Trading Volume Remains SubduedGrowth Stock Picks - dars.gov.et
Form 144 Sight Sciences For: 2 July By Investing.com - Investing.com Canada
SGHT (NASDAQ) Form 144 shows 6,902-share resale after restricted-vesting - Stock Titan
SGHT (NASDAQ) insider resale notice: 24,184 shares tied to vesting - Stock Titan
Form 144 Sight Sciences For: 1 July By Investing.com - Investing.com India
2,829 Restricted Shares for SGHT (NASDAQ: SGHT)Form 144 Notice - Stock Titan
Sight Sciences Inc Azioni (SGHT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sight Sciences Inc Azioni (SGHT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rodberg James | Chief Financial Officer |
Jul 02 '26 |
Sale |
5.36 |
6,902 |
36,995 |
224,037 |
| Badawi David | Chief Technology Officer |
Jul 06 '26 |
Sale |
5.51 |
7,418 |
40,858 |
1,982,872 |
| Taylor Brenton | EVP, Operations & R&D |
Jul 01 '26 |
Sale |
5.42 |
2,829 |
15,333 |
264,978 |
| Bauerlein Alison | Chief Operating Officer |
Jul 02 '26 |
Sale |
5.36 |
24,184 |
129,626 |
664,709 |
| Badawi Paul | President and CEO |
Jul 01 '26 |
Sale |
5.42 |
28,684 |
155,467 |
6,122,472 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):